WORLDWIDE CLINICAL TRIALS LIMITED
Get an alert when WORLDWIDE CLINICAL TRIALS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-07-09 (in 2mo)
Last made up 2025-06-25
Watchouts
None on the register
Cash
£9M
+35.2% vs 2023
Net assets
£15M
+94.5% vs 2023
Employees
382
+13.7% vs 2023
Profit before tax
£10M
+291.5% vs 2023
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £184,757,024 | £208,559,262 | |
| Operating profit | -£7,061,298 | £8,594,353 | |
| Profit before tax | -£5,200,466 | £9,958,317 | |
| Net profit | -£4,560,116 | £7,461,787 | |
| Cash | £6,997,190 | £9,459,484 | |
| Total assets less current liabilities | £9,343,829 | £16,596,665 | |
| Net assets | £7,842,887 | £15,257,142 | |
| Equity | £7,842,887 | £15,257,142 | |
| Average employees | 336 | 382 | |
| Wages | £36,501,329 | £25,465,285 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | -3.8% | 4.1% | |
| Net margin | -2.5% | 3.6% | |
| Return on capital employed | -75.6% | 51.8% | |
| Gearing (liabilities / total assets) | 90.0% | 84.9% | |
| Current ratio | 0.99x | 1.08x | |
| Interest cover | -26.32x | 29.64x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Cooper Parry Group Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Company had net current assets of £6,817,176 at 31 December 2024 (2023: net current liabilities of £448,576). In the directors' opinion, the Company can continue as a going concern in the light of the favourable trading outlook and the continued support that is available from the wider Worldwide Clinical Trials group.”
Group structure
- WORLDWIDE CLINICAL TRIALS LIMITED · parent
- WoWei Pharmaceutical Technology (Shanghai) Co, Ltd 100%
- Worldwide Clinical Trials UK Limited 100%
Significant events
- “Revenue increased by 13% in 2024, driven primarily by additions to Company bookings during the year, and the Company maintained its focus on specific areas of the market to continue to solidify its reputation of being an expert in the therapeutic areas it operates within.”
- “The operating loss in 2023 of £7,061,298 is predominantly attributable to payroll related expenses directly related to the acquisition of WCT Group Holdings, LLC, the Company's ultimate parent undertaking and controlling party, in December 2023.”
- “2024 has seen a continuation of the successes instigated by the changes in 2023. Internal restructuring and focus on talent acquisition continued into 2024 in the key areas of business development and therapeutic expertise.”
- “The Company continues to invest in research and development, particularly in relation to its proprietary clinical trial management software applications.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 11 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| DENTONS SECRETARIES LIMITED | Corporate Secretary | 2011-01-17 | — | — |
| BOWSER, David Michael | Director | 2024-04-30 | Apr 1967 | American |
| LEWIS, Gabrielle Ann | Director | 2026-02-09 | Oct 1984 | American |
| MACDONALD, Alistair John | Director | 2026-02-09 | Feb 1970 | British |
| MERRIMAN, Anthony Jason | Director | 2024-04-30 | Jul 1985 | British |
Show 11 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BUTLER, David Michael | Secretary | 2007-10-24 | 2023-12-12 |
| SIMMONS, Samuel | Secretary | 2007-06-25 | 2007-10-24 |
| MAWLAW SECRETARIES LIMITED | Corporate Secretary | 2007-10-24 | 2011-01-17 |
| BENTON, Peter Scobee | Director | 2024-04-30 | 2026-02-09 |
| BUTLER, David Michael | Director | 2007-10-24 | 2023-12-12 |
| CARTA, Angelico | Director | 2009-01-20 | 2024-05-31 |
| CUTLER, Neal Richard, Dr | Director | 2007-06-25 | 2009-01-20 |
| DENVIR, Michael Roger | Director | 2007-10-24 | 2023-05-01 |
| DORIGOTTI, Fabio | Director | 2009-01-20 | 2015-09-07 |
| LEDERMAN, Barry Alan | Director | 2024-04-30 | 2024-10-04 |
| SUFFREDINI, Peter | Director | 2009-01-20 | 2023-12-12 |
Ownership
Persons with significant control
Filing timeline
Last 20 of 93 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-02-10 | TM01 | officers | Termination director company with name termination date | |
| 2026-02-09 | TM01 | officers | Termination director company with name termination date | |
| 2026-02-09 | AP01 | officers | Appoint person director company with name date | |
| 2026-02-09 | AP01 | officers | Appoint person director company with name date | |
| 2025-10-16 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-10-16 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-10-03 | AA | accounts | Accounts with accounts type full | |
| 2025-06-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-12-23 | AA | accounts | Accounts with accounts type full | |
| 2024-07-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-06-05 | TM01 | officers | Termination director company with name termination date | |
| 2024-06-05 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-06-05 | TM01 | officers | Termination director company with name termination date | |
| 2024-06-05 | AP01 | officers | Appoint person director company with name date | |
| 2024-06-05 | AP01 | officers | Appoint person director company with name date | |
| 2024-06-05 | AP01 | officers | Appoint person director company with name date | |
| 2024-06-05 | AP01 | officers | Appoint person director company with name date | |
| 2024-06-04 | TM01 | officers | Termination director company with name termination date | |
| 2023-11-02 | AA | accounts | Accounts with accounts type full | |
| 2023-07-07 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 8
- Capital events
- 0
- Officers appointed
- 2
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+12.9%
£184,757,024 £208,559,262
-
Cash
+35.2%
£6,997,190 £9,459,484
-
Net assets
+94.5%
£7,842,887 £15,257,142
-
Employees
+13.7%
336 382
-
Operating profit
+221.7%
-£7,061,298 £8,594,353
-
Profit before tax
+291.5%
-£5,200,466 £9,958,317
-
Wages
-30.2%
£36,501,329 £25,465,285
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers